What Is Compounded Semaglutide?
Compounded semaglutide is a form of the diabetes medication semaglutide that is custom-prepared by compounding pharmacies. This service has become especially important due to frequent shortages of GLP-1 medications, including well-known brands like Wegovy®, Ozempic®, and Rybelsus®. Such shortages are often caused by manufacturing delays, rising demand and disruptions in the supply chain, leaving many patients without essential treatment. Compounded semaglutide offers a reliable alternative when these name-brand medications are not available.With state-of-the-art 503A and 503B facilities, Olympia Pharmaceuticals can tailor patient-specific prescriptions and office-use preparations of GLP-1 medications. Our adherence to stringent national and state regulations ensures that healthcare providers and their patients can maintain uninterrupted treatment.
What Is Compounded Semaglutide Prescribed For?
Semaglutide is primarily prescribed for adults with type 2 diabetes to improve blood glucose control. Additionally, it may be used for weight management in individuals who are either overweight or obese and have at least one weight-related condition, such as hypertension or dyslipidemia.Clinical trials have proven that semaglutide is effective in weight management when combined with a proper diet and exercise plan. It works by regulating blood sugar and digestion, curbing appetite, slowing the rate at which the stomach empties, and increasing feelings of fullness after meals. These effects collectively reduce total caloric intake, which is crucial for weight management.
It is important to use compounded semaglutide under the supervision of a healthcare professional. The benefits and risks of this medication should be carefully weighed on an individual basis. For lasting weight loss results, it is recommended to adopt a holistic approach that includes both medication and lifestyle changes.
Precautions/Side Effects
Like all medications, compounded semaglutide can cause side effects. The most common are gastrointestinal symptoms, including nausea, vomiting, diarrhea, abdominal pain and constipation. In some cases, more severe side effects may occur, such as pancreatic inflammation, vision changes or low blood sugar, especially when taken with other diabetes medications.
Individuals with a personal or family history of medullary thyroid carcinoma.
Those with Multiple Endocrine Neoplasia syndrome type 2.
Patients with a history of severe gastrointestinal disease, including gastroparesis, as semaglutide can slow gastric emptying.
People under 18 years of age, as its safety and efficacy in pediatric patients have not been established.
It is crucial to discuss all potential risks with a healthcare provider before starting treatment with semaglutide.
